Tofacitinib Impurity 2

Request For Quotation
Tofacitinib Impurity 2 Suppliers list
Company Name: Adamas Reagent, Ltd.  
Tel: 400-6009262 15618770481
Email: yhx@titansci.com
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Wuxi Zhongkun Biochemical Technology Co., Ltd.  
Tel: 0510-85629785 18013409632;
Email: sales@reading-chemicals.com
Company Name: Shanghai Kewel Chemical Co., Ltd.  
Tel: 021-64609169 18901607656
Email: greensnown@163.com
Company Name: Hubei Yangxin Medical Technology Co., Ltd.  
Tel: 15374522761
Email: 3003392093@yongstandards.com

Tofacitinib Impurity 2 manufacturers

  • Tofacitinib Impurity 2
  • Tofacitinib Impurity 2 pictures
  • $6.00
  • 2020-01-10
  • CAS:1616760-97-4
  • Min. Order: 1KG
  • Purity: 98%
  • Supply Ability: 1kg, 5kg, 50kg
Tofacitinib Impurity 2 Basic information
Product Name:Tofacitinib Impurity 2
Synonyms:Tofacitinib-30;Tofacitinib impurity 5/2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo [2,3-d]pyrimidin-4-amine;Tofacitinib Imp.E;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-((3R,4R)-4-methyl-piperidin-3-yl)-N-methyl-2-chloro-7H-pyrrolo[2,3-D]pyrimidine-4-amine;Azilsartan medoxomil impurity327;Tofatinib Impurity E
CAS:1616760-97-4
MF:C13H18ClN5
MW:279.77
EINECS:
Product Categories:
Mol File:1616760-97-4.mol
Tofacitinib Impurity 2 Structure
Tofacitinib Impurity 2 Chemical Properties
density 1.290±0.06 g/cm3(Predicted)
pka12.46±0.50(Predicted)
Safety Information
MSDS Information
Tofacitinib Impurity 2 Usage And Synthesis
Tofacitinib Impurity 2 Preparation Products And Raw materials
Tag:Tofacitinib Impurity 2(1616760-97-4) Related Product Information
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine 3-Piperidinamine,4-methyl-1-(phenylmethyl)-,(3R,4R)-rel- methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide 3-Amino-4-methylpyridine (3R,4R)-N,4-dimethyl-piperidin-3-amine Tofacitinib impurity 1 Tofacitinib Impurity 6 3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-Methoxycarbonylamino-4-methylpyridine Cyanoacetic acid-OSu 4-Methyl-3-methylaminopyridine